Concepedia

Sandra J. Sivananthan

SJ

Statistics

Publications

9

Citations

373

H-Index

9

Active since

2010

Affiliations

Infectious Disease Research Institute(Current)

University of Washington

PAI Life Sciences (United States)

TechLab (United States)

Access to Wholistic and Productive Living Institute

Sandra J. Sivananthan is an author at Infectious Disease Research Institute specializing in vaccinology, vaccine delivery, and pharmaceutics.

Publications per year

2010–2023

9

Publications

9

Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis

Mark T. Orr, Christopher B. Fox, Susan L. Baldwin et al. · Journal of Controlled Release · 2013 · 103 citations

Veterinary Medicine, Immunology, Pharmaceutics +14

A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7

Christopher B. Fox, Sandra J. Sivananthan, Malcolm S. Duthie et al. · Journal of Nanobiotechnology · 2014 · 79 citations · Full text

Pharmacy, Immunology, Pharmacology +17

Particle Sizing of Nanoparticle Adjuvant Formulations by Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA)

Michelle Y. Chan, Quinton M. Dowling, Sandra J. Sivananthan et al. · Methods in molecular biology · 2016 · 58 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +17

Control of Heterologous Simian Immunodeficiency Virus SIV <sub>smE660</sub> Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques

Shakti Singh, Eric G. Ramírez-Salazar, Rami Doueiri et al. · Journal of Virology · 2018 · 37 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions

Christopher B. Fox, Susan Lin, Sandra J. Sivananthan et al. · Pharmaceutical Development and Technology · 2010 · 28 citations

Pharmacy, Bioengineering, Pharmaceutics +14

1–5 of 9